Transitional cell carcinoma

Common Name(s)

Transitional cell carcinoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Transitional cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Transitional cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Transitional cell carcinoma" returned 379 free, full-text research articles on human participants. First 3 results:

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder.
 

Author(s): S Hafeez, A Horwich, O Omar, K Mohammed, A Thompson, P Kumar, V Khoo, N Van As, R Eeles, D Dearnaley, R Huddart

Journal: Br. J. Cancer. 2015 May;112(10):1626-35.

 

Radiotherapy for muscle invasive bladder cancer (MIBC) aims to offer organ preservation without oncological compromise. Neo-adjuvant chemotherapy provides survival advantage; response may guide patient selection for bladder preservation and identify those most likely to have favourable ...

Last Updated: 13 May 2015

Go To URL
Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study.
 

Author(s): Azik Hoffman, Ofer Yossepowitch, Yaron Erlich, Ronen Holland, David Lifshitz

Journal:

 

There is paucity of data as to the results of the endoscopic approach in comparison to the golden standard of nephro-ureterectomy in elective, low grade TCC, patients. Our purpose is to report our results of a nephron sparing approach compared to nephro-ureterectomy in those patients.

Last Updated: 9 Dec 2014

Go To URL
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
 

Author(s): Daniel Castellano, Javier Puente, Guillermo de Velasco, Isabel Chirivella, Pilar López-Criado, Nicolás Mohedano, Ovidio Fernández, Icíar García-Carbonero, María Belén González, Enrique Grande

Journal:

 

Patients with transitional cell carcinoma of the urothelial tract (TCCU) who fail initial platinum-based chemotherapy for advanced disease represent a challenge in daily clinical practice. Vinflunine is approved by the European Medicine Agency (EMA) but, up to now, limited experience ...

Last Updated: 31 Oct 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Transitional cell carcinoma" returned 24 free, full-text review articles on human participants. First 3 results:

Complete remission of primary retroperitoneal transitional cell carcinoma after radiotherapy and oral chemotherapy: a case report.
 

Author(s): K Ichinohe, M Ijima, T Usami, S Baba

Journal: Ann R Coll Surg Engl. 2013 Mar;95(2):e52-4.

 

Primary retroperitoneal transitional cell carcinomas (TCCs) are extremely rare neoplasms for which prognosis is very poor. We present a case that underwent complete remission after radiotherapy and concurrent oral chemotherapy. A 68-year-old woman presented with acute onset of bloody ...

Last Updated: 14 Mar 2013

Go To URL
Cutaneous metastasis of transitional cell bladder carcinoma: a rare presentation and literature review.
 

Author(s): Nikolaos S Salemis, Christos Gakis, Andreas Zografidis, Stavros Gourgiotis

Journal: J Cancer Res Ther. ;7(2):217-9.

 

Cutaneous metastasis from transitional cell bladder carcinoma is a rare clinical entity associated with poor prognosis. We present a case of cutaneous metastasis arising from a transitional cell bladder carcinoma in a male patient who had undergone a radical cystectomy and bilateral ...

Last Updated: 19 Jul 2011

Go To URL
Intracranial metastasis from primary transitional cell carcinoma of female urethra: case report & review of the literature.
 

Author(s): Kyung-Sub Moon, Shin Jung, Kyung-Hwa Lee, Eu Chang Hwang, In-Young Kim

Journal:

 

Transitional cell carcinoma (TCC) of the female urethra is a rare urological malignancy, and intracranial metastasis of this cancer has not yet been reported in the literature. This review is intended to present a case of multiple intracranial metastasis in a female patient with a ...

Last Updated: 7 Feb 2011

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
 

Status: Recruiting

Condition Summary: Transitional Cell Carcinoma

 

Last Updated: 23 Jan 2013

Go to URL
Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
 

Status: Recruiting

Condition Summary: Urothelium Transitional Cell Carcinoma

 

Last Updated: 27 Jan 2014

Go to URL
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
 

Status: Recruiting

Condition Summary: Transitional Cell Carcinoma; Bladder Carcinoma; Urothelial Carcinoma

 

Last Updated: 13 Mar 2015

Go to URL